Patents by Inventor Adam Michael Cable

Adam Michael Cable has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250172575
    Abstract: A device is presented for storing, transporting, measuring, and collecting blood, having the properties of a precisely determined volume, and a geometry suitable for the entire device to be efficiently placed in the counting chamber of a detector, such as the counting well of a gamma counter. Also presented are a system and method for determining the Hematocrit (Hct) of a subject.
    Type: Application
    Filed: November 25, 2024
    Publication date: May 29, 2025
    Applicant: DAXOR CORP.
    Inventors: Jonathan Feldschuh, Adam Michael Cable, Jackson Rieb, Linda J. Cooper
  • Publication number: 20230131712
    Abstract: Systems and methods are provided for measuring blood volume of a living being using fluorescent dye. The present invention greatly simplifies the performance of a blood volume measurement by utilizing a novel fluorescent tracer. An injection and sampling kit for the performance of an indicator dilution measurement, comprising a) a labelled fluorescent injectate, and b) a plurality of collection cassettes, and a calibration kit comprising a plurality of calibrated standard cassettes of identical conformation to the cassettes in b), corresponding to known dilutions of the injectate (a).
    Type: Application
    Filed: April 29, 2021
    Publication date: April 27, 2023
    Applicant: DAXOR CORP.
    Inventors: Jonathan Feldschuh, Atilio Anzellotti, Nancy Tommye Jordan, Boyce Lee Muller, Robin D. Zimmer, Adam Michael Cable
  • Publication number: 20230049988
    Abstract: Pharmaceutical compositions and methods are presented for creating a ternary structure involving a fluorescent molecule, an intermediate carrier molecule, and a larger protein or polymer with a binding site receptive to the intermediate molecule or fluorescent/intermediate complex. The resulting ternary system improves the binding stability of the fluorescent dye to the protein, both in-vivo and in-vitro. This improved stability results in a longer half-life in medical use, enabling improved qualitative and quantitative use of the dye.
    Type: Application
    Filed: April 29, 2021
    Publication date: February 16, 2023
    Applicant: DAXOR CORP.
    Inventors: Jonathan Feldschuh, Atilio Anzellotti, Nancy Tommye Jordan, Boyce Lee Muller, Robin D. Zimmer, Adam Michael Cable
  • Patent number: D1128083
    Type: Grant
    Filed: November 30, 2023
    Date of Patent: May 26, 2026
    Assignee: DAXOR CORP.
    Inventors: Jonathan Feldschuh, Adam Michael Cable, Jackson Rieb, Linda J. Cooper